sinceasdf@lemmy.worldtoNews@lemmy.world•Supreme Court rejects multibillion-dollar Purdue Pharma opioid settlement that shielded billionaire Sackler family
2·
3 months agoI think there is likely to still be just as large of a personal variance in the rate that lisdexamphetamine is cleaved into the active metabolite, so the same problem arises.
I think anything that delays the active metabolite from taking effect technically dampens the addictive potential; the longer the better. I also think it’s unlikely to really solve the problem though tbh. People can still tell what’s causing how they feel when they start a new medication.
Lmao benzinga the pinnacle of science news
There is a real study it’s referencing at least but these fucks are probably just trying to pump weed stocks